- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Norris Medicines Limited has secured a favorable ruling from the Bombay High Court. The court allowed the company's appeal, setting aside a previous order that required Norris Medicines and its Director to deposit ₹1.33 Cr, along with 18% simple interest annually. This earlier deposit requirement stemmed from an order under the MPID Act. The High Court's decision follows the acquittal in the related MPID Special Case, making the deposit order unsustainable. This outcome removes a significant financial liability and resolves a long-standing legal matter for the company.